Amneal adds to women’s health lineup

Print Friendly, PDF & Email

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has expanded its portfolio of women’s health products with the release of Femynor, a birth control pill.

femynor-tablets_amnealAmneal said Femynor (norgestimate and ethinyl estradiol tablets, 0.25 mg/0.035 mg) is a generic version of Ortho-Cyclen 28 from Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Femynor is sold in a 28-count blister pack.

U.S. sales of Ortho-Cyclen 28 and its generic equivalents totaled $178.3 million for the 12 months ended in June, according to IMS Health data reported by Amneal.

Amneal noted that the Femynor launch gives its women’s health line six products, including the company’s recently launched Larissia (levonorgestrel and ethinyl estradiol tablets), three other oral contraceptives and two hormone replacement therapies.

The drug maker added that a first-to-market generic launch is also planned for early October, along with five additional oral contraceptives over the next few months.


Comments are closed.